'Go and get 'em, folks': All adults in US now eligible for COVID-19 vaccine

President Joe Biden urged Americans to “please, get the vaccine” on Monday as all adults in the U.S. are now eligible to receive the shot, another major milestone reached in the ongoing effort to defeat the pandemic.

Lawmakers add COVID-19 passport ban to bill limiting local governments' emergency powers

A House committee Monday approved a proposal that would limit local emergency orders and make permanent Gov. Ron DeSantis’ executive order barring COVID-19 “passports” that would show people have been vaccinated.

Multiple over-the-counter COVID-19 tests now available at stores nationwide

Multiple COVID-19 tests will be available at stores nationwide beginning this week, without the need for a prescription. They range in price from $23.99 to $119.99.

India's capital to lock down amid devastating coronavirus surge

New Delhi imposed a weeklong lockdown Monday night amid an explosive surge in coronavirus cases to prevent the collapse of the Indian capital's health system.

NIH funds new COVID-19 testing initiative to get students back to classrooms in vulnerable areas

While other studies are looking at physical distancing and other ways to keep children safe at school, this NIH initiative focuses solely on how to best implement COVID-19 testing among the students, teachers and staff.

Fauci says he expects J&J vaccine to resume later this week

The United States will likely move to resume Johnson & Johnson’s COVID-19 vaccine this coming week, possibly with restrictions or broader warnings after reports of some very rare blood clot cases, Dr. Anthony Fauci said.

Some people may have to return their $1,400 stimulus check

While a lot of people who received the third stimulus check could really use it, unfortunately, some people may have to return the $1,400.

Biden administration to invest $1.7B to identify, track coronavirus variants

The Biden administration says the U.S. is setting up a $1.7 billion national network to identify and track worrisome coronavirus mutations whose spread could trigger another pandemic wave.

Vacant middle seats on airplanes cut COVID-19 exposure risk by up to 57%, CDC study says

Leaving middle seats open and vacant on airplanes may significantly reduce a passenger’s risk of exposure to the coronavirus, a new study published by the U.S. Centers for Disease Control and Prevention suggests.

Pfizer CEO says third dose of vaccine 'likely' needed within 1 year

The CEO of pharmaceutical giant Pfizer said during a televised interview Thursday that people will "likely" need a third dose of the COVID-19 vaccine.

CDC identifies 5,800 COVID-19 ‘breakthrough infections’ among 75 million fully vaccinated people

The U.S. Centers for Disease Control and Prevention says it has identified a comparatively small group of fully vaccinated people who have reported “breakthrough” COVID-19 infections, which should be “expected.”

FEMA’s COVID-19 funeral assistance hotline inundated with more than 1M calls on 1st day

FEMA said it was inundated with over 1 million calls from people requesting assistance with COVID-19-related funeral expenses on its first day of application processing.

Unemployment claims fall to 576,000, lowest since COVID-19 pandemic began

The number of Americans applying for unemployment benefits fell sharply last week to 576,000, a hopeful sign that layoffs are easing as the economy recovers from the pandemic recession.

Most kids with MIS-C had mild COVID-19, some also developed neurological symptoms, research shows

New research has found that most kids with a serious inflammatory illness linked to the coronavirus had no COVID-19 symptoms or just mild ones. Another small study found that many MIS-C patients also suffered neurological symptoms.

Pollen could play role increased COVID-19 infection rates, study suggests

The spring season correlates with increased pollen counts, and according to a new study, the common allergen could be making COVID-19 infection rates worse.

J&J COVID-19 vaccine pause to remain in place while officials seek more evidence on rare clots

The pause on Johnson & Johnson’s COVID-19 vaccine will remain in place for now after U.S. health advisers said they need more evidence to make any decision about the rare blood clots reported.

2 new studies find UK B.1.1.7 coronavirus variant more transmissible, but not linked to COVID-19 severity

Two new studies analyzing the worrisome B.1.1.7 coronavirus variant that first emerged in the U.K. found that while the strain is more transmissible, it did not appear to cause more severe COVID-19 illness.